Listed Companies

ANZ takes $22m stake in Pacific Edge

Dan Brunskill
Fri, 24 Jul 2020

ANZ takes $22m stake in Pacific Edge
Dan Brunskill
Fri, 24 Jul 2020
ANZ New Zealand Investments has bought $22 million of new shares in cancer diagnostics company Pacific Edge at a premium. Pacific Edge will issue 33.8 million shares to ANZ at 65 cents per share, a 14 percent premium to the volume weighted average share price over the previous 5-day trading period. The company currently has more than 689 million shares on issue.  The share price jumped 17.24 percent to 68 cents in early trading, up 467 percent year-to-date. The investment from ANZ follows Pacific Edge’s breakthrough in the United State...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets FREE
Eroad shares fall to all-time low
Ella Somers | Thu, 30 Jun 2022

Fleet management company Eroad dropped 3.4% to $1.42 today – its lowest share price since 2016.

Finance
Finlay steps down as NZ Post chair as he joins RBNZ board
Jenny Ruth | Thu, 30 Jun 2022

No mention was made of Rodger Finlay's term ending as chair of NZ Post when controversy over his appointment to RBNZ's new board blew up earlier this month.

Opinion
My bet? Ardern says the EU-NZ FTA needs more work
Rebecca Howard | Thu, 30 Jun 2022

Arden’ll just say it’s very close, but more talks are needed. That’s much easier to spin than a deal at any cost.

Sponsored
Digital innovation could shape the future of NZ

The digital age allows us to collaborate on some of our greatest scientific and environmental challenges

Sponsored
Investments to sustain the momentum of building in NZ

Classic Capital has opened its Land & Build fund to qualified wholesale and eligible investors.